ATE302022T1 - Verwendung von il-11 zur behandlung von entzündung - Google Patents

Verwendung von il-11 zur behandlung von entzündung

Info

Publication number
ATE302022T1
ATE302022T1 AT96921237T AT96921237T ATE302022T1 AT E302022 T1 ATE302022 T1 AT E302022T1 AT 96921237 T AT96921237 T AT 96921237T AT 96921237 T AT96921237 T AT 96921237T AT E302022 T1 ATE302022 T1 AT E302022T1
Authority
AT
Austria
Prior art keywords
disorders
arthritis
treat inflammation
cva
spondyloarthropathies
Prior art date
Application number
AT96921237T
Other languages
English (en)
Inventor
James Keith
Paul Schendel
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Application granted granted Critical
Publication of ATE302022T1 publication Critical patent/ATE302022T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
AT96921237T 1995-06-27 1996-05-30 Verwendung von il-11 zur behandlung von entzündung ATE302022T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/495,724 US5679339A (en) 1995-06-27 1995-06-27 Method of using IL-11 for treating spondyloarthropies
PCT/US1996/008059 WO1997001353A1 (en) 1995-06-27 1996-05-30 Use of il-11 to treat inflammation

Publications (1)

Publication Number Publication Date
ATE302022T1 true ATE302022T1 (de) 2005-09-15

Family

ID=23969764

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921237T ATE302022T1 (de) 1995-06-27 1996-05-30 Verwendung von il-11 zur behandlung von entzündung

Country Status (8)

Country Link
US (4) US5679339A (de)
EP (2) EP0835128B1 (de)
JP (1) JPH11508556A (de)
AT (1) ATE302022T1 (de)
AU (1) AU724626B2 (de)
CA (1) CA2220554A1 (de)
DE (1) DE69635079T2 (de)
WO (1) WO1997001353A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6540993B1 (en) * 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US6887461B1 (en) 1998-10-26 2005-05-03 Genetics Institute, Llc Method of using IL-11 for treating mucositis
AUPO439396A0 (en) * 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
US6660258B1 (en) * 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
US5981499A (en) * 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
US6953777B2 (en) * 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
MXPA00012560A (es) 1999-04-15 2003-08-20 Inst Genetics Llc Uso de interleucocina-11 para tratar desordenes gastrointestinales.
HUP0301349A3 (en) * 1999-07-15 2005-12-28 Genetics Inst Llc Cambridge Formulations for il-11
US6248718B1 (en) 1999-08-18 2001-06-19 Atlantic Biomed Corporation Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
US20040062757A1 (en) * 2001-06-05 2004-04-01 Finegold Sydney M. Method of testing gastrointestinal diseases associated with species of genus clostridium
US20020013270A1 (en) * 2000-06-05 2002-01-31 Bolte Ellen R. Method for treating a mental disorder
GB0021668D0 (en) * 2000-09-04 2000-10-18 Smithkline Beecham Plc New use
WO2003049693A2 (en) * 2001-12-06 2003-06-19 Wyeth Method and composition for inducing weight loss
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
JP2006503045A (ja) * 2002-09-16 2006-01-26 ワイエス ポリペプチド治療薬剤の経口投与のための遅延放出処方物と同薬剤の使用方法
US20040121991A1 (en) * 2002-12-20 2004-06-24 Araneo Barbara A. Dehydroepiandrosterone (DHEA) congeners for prevention and/or treatment of ulcers
US20080069796A1 (en) * 2006-07-31 2008-03-20 Kim Jong-Mook Low Dose Treatment with an Interleukin-11 Analog
WO2008050789A1 (fr) 2006-10-27 2008-05-02 The New Industry Research Organization Utilisation de l'interleukine-11 en tant qu'agent thérapeutique pour une cardiopathie
US20100119476A1 (en) * 2007-03-05 2010-05-13 University Of North Carolina At Chapel Hill Selection of peptides specific for human blood outgrowth endothelial cells
WO2008109653A2 (en) * 2007-03-05 2008-09-12 The University Of North Carolina At Chapel Hill Peptides specific for human blood outgrowth endothelial cells
US8182814B2 (en) * 2007-10-26 2012-05-22 Csl Limited Methods of treating inflammatory airway conditions by inhibition of IL-11 activity
US9707207B2 (en) 2010-05-26 2017-07-18 The United States Of America As Represented By The Department Of Veterans Affairs Method for diagnosing, preventing, and treating neurological diseases
WO2011154413A1 (en) 2010-06-07 2011-12-15 Fritz-Lipmann-Insitut E. V. Leibniz-Institut Für Altersforschung Agent against glucocorticoid-induced osteoporosis
US9198975B2 (en) 2010-12-01 2015-12-01 The University Of North Carolina At Chapel Hill Methods and compositions for targeting sites of neovascular growth
GB201522186D0 (en) 2015-12-16 2016-01-27 Singapore Health Services Pte Ltd And Nat University Of Singapore The Treatment of fibrosis
WO2017201322A1 (en) * 2016-05-19 2017-11-23 Cortexyme, Inc. Treatment of osteoarthritis with gingipain blocking agents
CA3045871A1 (en) 2016-12-16 2018-06-21 Singapore Health Services Pte Ltd Il-11 antibodies
GB201621439D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
CN113677706A (zh) 2019-01-21 2021-11-19 新加坡保健服务私人有限公司 肝毒性的治疗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5460810A (en) * 1992-09-02 1995-10-24 Genetics Institute, Inc. Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
US5543138A (en) * 1994-03-10 1996-08-06 Genetics Institute, Inc. Methods of diagnosing and treating preeclampsia

Also Published As

Publication number Publication date
JPH11508556A (ja) 1999-07-27
EP0835128A1 (de) 1998-04-15
EP1579868A2 (de) 2005-09-28
US6270759B1 (en) 2001-08-07
AU6250596A (en) 1997-01-30
EP1579868A3 (de) 2005-10-19
DE69635079T2 (de) 2006-06-29
US5948402A (en) 1999-09-07
US5679339A (en) 1997-10-21
US5958401A (en) 1999-09-28
DE69635079D1 (de) 2005-09-22
AU724626B2 (en) 2000-09-28
WO1997001353A1 (en) 1997-01-16
CA2220554A1 (en) 1997-01-16
EP0835128B1 (de) 2005-08-17

Similar Documents

Publication Publication Date Title
ATE302022T1 (de) Verwendung von il-11 zur behandlung von entzündung
DE69908648D1 (de) Kondensierte 1,2,4-thiadiazinderivate, ihre herstellung und verwendung
DE69829412D1 (de) Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
ATE149483T1 (de) Kristalle von n-(trans-4- isopropylcyclohexylcarbonyl)-d-phenylalanin und verfahren zu ihrer herstellung
DE3580803D1 (de) Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2-azetidinonen.
DE69413138D1 (de) Verfahren zur Bildung von Beschichtungen aus kristallinem Siliziumcarbid
DE69527469T2 (de) Verfahren zur Erzeugung von Ozon
DE69432796D1 (de) Kombination von dna-sequenzen, die die bildung von modifizierter stärke in pflanzenzellen und pflanzen ermöglicht, verfahren zur herstellung dieser pflanzen
DE19680622D2 (de) Verfahren zum Herstellen von Siliciumcarbid-Einkristallen
DE3883518D1 (de) Verfahren zur Herstellung von Silicium-Metall hoher Reinheit und Vorrichtung dafür.
DE59903993D1 (de) Verfahren zur herstellung von epothilon b und derivaten davon
BR9406421A (pt) Aparelho para controlar a adição de modificador de desaguamento químico e para flocular uma suspensão e para desaguar a suspensão floculada processo para desaguar uma suspensão e conjunto de filtração
IT1226382B (it) Processo e impianto per la produzione di mattonelle e di materiaprima per la produzione di silicio o di carburo di silicio o di ferrosilicio
DE59402715D1 (de) Verfahren zur elektrochemischen Synthese von Organosiliciumverbindungen sowie eine Vorrichtung zur Durchführung des Verfahrens und ihre Verwendung zur Herstellung von Organosiliciumverbindungen
ATE355517T1 (de) Vorrichtung und verfahren zum messen der konzentration von ionen in einer messflüssigkeit
DE58901791D1 (de) Verfahren und anlage zum herstellen von dekorgranulaten sowie verwendung dieser granulate.
DE69614936T2 (de) d4T polymorphe Form I Verfahren
DE60041330D1 (de) Methode zur erzeugung von chips aus dünnen plättchen pyroelektrischen materials
DE60328431D1 (de) Verfahren zum Raffinieren von anorganischen Kurzfasern
DE69331094T2 (de) Verfahren zur Herstellung von essfertigen Getreideflocken
DE69800092T2 (de) Substituierte 4-(6-fluor-[1H]-indol-3-yl)1,2,3,6-Tetrahydropyridin-Derivate für die Behandlung von ZNS-Störungen
EP0293716A3 (de) Polyhydrobenz(c,d)indolsulfonamide
ES8205203A1 (es) Un procedimiento para la preparacion de derivados del imidazol.
DE69707114D1 (de) 3-aryl-r-carboxyalkyl substituierte glutarimide, ihre herstellung durch ringschluss von 4-aryl-4-cyanoheptandicarbonsäuren und ihre verwendung zur herstellung von 3-aryl-3-hydroxyalkylpiperidinen
ATA221292A (de) Neues verfahren zur herstellung von 3-vinylcephalosporinverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0835128

Country of ref document: EP

REN Ceased due to non-payment of the annual fee